Publication:
Evaluating fluoroquinolone use in patients admitted to the tuberculosis outpatient clinic

dc.contributor.coauthorOnur, Seda Tural
dc.contributor.coauthorOrtaköylü, Mediha Gönenç
dc.contributor.kuauthorİliaz, Sinem
dc.contributor.kuprofileDoctor
dc.contributor.unitKoç University Hospital
dc.contributor.yokid168584
dc.date.accessioned2024-11-09T12:31:03Z
dc.date.issued2016
dc.description.abstractObjective: Inelaborate use of new quinolones with strong anti-tuberculosis (TB) activity leads to difficulty in diagnosis and more importantly, quinolone-resistant Mycobacterium tuberculosis. We aimed to determine the frequency of quinolone use in patients who were referred to our hospital for suspected TB and to evaluate the association between quinolone use and different clinical laboratory parameters. Methods: Between November 15 and December 15, 2013, all patients who were admitted to the TB outpatient clinic with no previous diagnosis of TB were included in this study. Demographic and clinical laboratory findings and history of antibiotic use were recorded. Patients' quinolone use were questioned by showing fluoroquinolone antibiotic boxes' photographs available on the market. The departments of the doctors who prescribed quinolones were recorded. Results: The mean age of 179 patients included in the study was 37 +/- 16 (15-89) years. Among these, 113 patients (63.1%) were male. Seventy five patients (41.9%) were diagnosed as tuberculosis according to the clinical-radiological and/or bacteriological findings. Of 179 patients, 58.1% (n=104) had been prescribed antibiotics for current complaints before referral to our clinic. Sixteen patients (15%) had been recommended fluoroquinolones. Fluoroquinolones were prescribed by seven internal medicine specialists, five pulmonologists, three emergency medicine specialists, and one family medicine practitioner. Among 16 fluoroquinolones prescribed, nine were moxifloxacin, four were levofloxacin, and three were gemifloxacin. Quinolone use revealed a significant inverse relationship only with the presence of hemoptysis (p=0.04). Conclusion: Besides increased educational activities regarding the rational use of antibiotics in recent years, the quinolone group of antibiotics is still prescribed for suspected TB cases. To avoid quinolone-resistant M. tuberculosis strains, further education is required.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyTR Dizin
dc.description.openaccessYES
dc.description.publisherscopeNational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume18
dc.formatpdf
dc.identifier.doi10.5152/ejp.2016.63935
dc.identifier.eissn2148-5402
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR00943
dc.identifier.issn2148-3620
dc.identifier.linkhttps://doi.org/10.5152/ejp.2016.63935
dc.identifier.quartileN/A
dc.identifier.urihttps://hdl.handle.net/20.500.14288/1924
dc.identifier.wos382875700009
dc.keywordsAntibiotics
dc.keywordsFluoroquinolones
dc.keywordsInfection
dc.keywordsPneumonia
dc.keywordsTuberculosis
dc.languageEnglish
dc.publisherAves
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/950
dc.sourceEurasian Journal of Pulmonology
dc.subjectMedicine
dc.subjectRespiratory system
dc.titleEvaluating fluoroquinolone use in patients admitted to the tuberculosis outpatient clinic
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorİliaz, Sinem

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
950.pdf
Size:
148.18 KB
Format:
Adobe Portable Document Format